Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Celgene
Celgene
Bristol-Myers Squibb completes $74bn acquisition of biotechnology firm Celgene
Pharmaceutical Business Review
Thu, 11/21/19 - 10:14 am
M&A
Bristol-Myers Squibb
Celgene
AZ, Merck and Novartis top Big Pharma's Q3 growth charts. Teva and Pfizer? Not so much
Fierce Pharma
Tue, 11/19/19 - 11:38 pm
earnings
Big Pharma
AstraZeneca
Merck
Celgene
Novartis
Novo Nordisk
Pfizer
Bristol-Celgene Merger Leaps FTC Clearance; Deal Set To Close Wednesday
Investors Business Daily
Sat, 11/16/19 - 10:30 pm
Bristol-Myers Squibb
Celgene
FTC
M&A
Editas and Celgene sub Juno are tackling hottest immunotherapy cells
Endpoints
Tue, 11/12/19 - 08:07 pm
Editas Medicine
Celgene
Juno Therapeutics
CRISPR
gene editing
immunotherapy
Celgene's last hurrah at ASH a defining moment for Bristol-Myers' buyout
Biopharma Dive
Sun, 11/10/19 - 07:56 pm
ASH
Celgene
M&A
Bristol-Myers Squibb
liso-cel
FDA Approves Celgene and Acceleron's Treatment for Rare Blood Disease
BioSpace
Sat, 11/9/19 - 12:13 pm
Celgene
Acceleron
Reblozyl
anemia
beta thalassemia
Celgene posts pivotal CAR-T data ahead of FDA filing
Fierce Biotech
Thu, 11/7/19 - 10:28 am
Celgene
CAR-T
liso-cel
Kymriah
Yescarta
The Week Ahead In Biotech: Adcom Test For Agile; Pfizer, Merck Lead Earnings
Yahoo/Benzinga
Sun, 10/27/19 - 10:55 pm
Adamis Pharmaceuticals
Redhill Biopharma
Amag Pharmaceuticals
Arqule
Agile Therapeutics
Agios Pharmaceuticals
Deciphera
Mirati Therapeutics
Sutro BioPharma
Merck
Pfizer
Amgen
EXACT Sciences
Bristol-Myers Squibb
Celgene
Oyster Point Pharma
Factors Setting the Tone for Celgene (CELG) Q3 Earnings
Yahoo/Zacks.com
Thu, 10/24/19 - 10:30 am
Celgene
earnings
Bristol-Myers Squibb Company Announces Extension of the Expiration Date for Exchange Offers for Celgene Corporation
Yahoo/Businesswire
Sun, 10/20/19 - 05:27 pm
Bristol-Myers Squibb
Celgene
M&A
A change of the guard for the world’s biggest cancer companies
EP Vantage
Fri, 10/18/19 - 10:16 am
cancer
Bristol-Myers Squibb
Celgene
M&A
Roche
AstraZeneca
As Celgene becomes BMS, its I&I lead lands CEO job at Takeda spinoff
Fierce Biotech
Fri, 09/27/19 - 10:08 am
Celgene
Bristol-Myers Squibb
M&A
Terrie Curran
Phathom
3 Biotechs With the Biggest Cash Stockpiles
Motley Fool
Fri, 09/20/19 - 09:27 am
biotech
cash
Gilead Sciences
Amgen
Celgene
Roche and Celgene set for battle in acute myelogenous leukaemia
EP Vantage
Wed, 09/18/19 - 09:54 am
Celgene
Roche
AML
acute myeloid leukemia
CC-486
Venclexta
Celgene's AML drug clears late-stage test
Endpoints
Mon, 09/16/19 - 09:17 am
Celgene
AML
CC-486
acute myeloid leukemia
Celgene's phase 3 AML test chalks up a win
Fierce Biotech
Fri, 09/13/19 - 10:52 am
Celgene
acute myeloid leukemia
CC-486
clinical trials
[podcast+transcript]Why Amgen's Spending Billions to Buy This 1 Drug
Motley Fool
Sat, 09/7/19 - 06:16 pm
FTC
Amgen
Celgene
Bristol-Myers Squibb
M&A
Otezla
EMA follows FDA to approve Roche's Tecentriq combo for frontline use in triple negative breast cancer
Endpoints
Thu, 08/29/19 - 12:26 pm
Roche
Tecentriq
FDA
Europe
Celgene
Abraxane
triple negative breast cancer
Mark Your Calendar For These September PDUFA Dates
Yahoo/Benzinga
Wed, 08/28/19 - 12:53 pm
FDA
Roche
Celgene
Tecentriq
Xeris Pharmaceuticals
Gvoke
Ardelyx
tenapanor
Merck
Pifeltro
Delstrigo
Novo Nordisk
semaglutide
JNJ
Genmab
daratumumab
Invokana
Yes, Amgen overpaid for Otezla—but that doesn't make it a mistake: analysts
Fierce Pharma
Wed, 08/28/19 - 12:47 pm
Amgen
Otezla
Enbrel
drug reps
M&A
Celgene
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »